NTRK3 and Parkinson disease: TrkC is highly expressed in the hippocampus, contributing to hippocampus hyperexcitability and aberrant fear circuit activation. The recovery of fear memory by tiagabine administered locally in the hippocampus might lead to new therapeutic options in PD.